Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule)
Open Access
- 1 January 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 57 (663) , 19-22
- https://doi.org/10.1136/pgmj.57.663.19
Abstract
Summary: Seventeen adult patients with previously untreated acute lymphoblastic leukaemia (ALL) were entered into a schedule of chemotherapy in which 3 combinations, each of 4 drugs, were administered in a predetermined cyclical rotation in combination with cranial irradiation and intrathecal injections of methotrexate. Of the 17 patients, 16 completed induction therapy and 15 (94%) entered remission. The only patient with T-ALL died before receiving any therapy. The median survival for all patients (17) was 22 months. Meningeal leukaemia did not occur during the haematological remission phase although 3 patients developed this complication following relapse. The authors conclude that the addition of cyclophosphamide and cytosine arabinoside to vincristine/prednisone provides excellent remission induction but the aggressive maintenance schedule employed has not led to significant long-term survival.This publication has 16 references indexed in Scilit:
- Therapeutic role of cell kinetics in acute leukaemiaClinics in Haematology, 1978
- Combination chemotherapy for acute lymphoblastic leukaemia in adults.BMJ, 1978
- ACUTE LYMPHOBLASTIC LEUKÆMIA IN CHILDREN: CLASSIFICATION AND PROGNOSISThe Lancet, 1977
- Early central nervous system involvement in adults with acute non-myelogenous leukaemiaBritish Journal of Cancer, 1977
- Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen).BMJ, 1975
- Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973).1975
- Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.1972
- Chemotherapy of acute leukaemiaClinics in Haematology, 1972
- Treatment of acute leukemia.1969
- Treatment of Acute LeukemiaAnnals of Internal Medicine, 1968